Media Centre

About Epistocks

What’s our name?

Epistocks

When were we founded?

2016

Where are we based?

Epistocks has global offices spread across multiple jurisdictions including London, Gibraltar, Limassol , Singapore, Melbourne and Minsk.

What do we sell and who do we sell it to?

Epistocks provides a regulated investment trading environment to enable people to securely trade and invest in the financial markets. Through our simple, intuitive trading platform, available on both web and app formats, people can trade and invest in over 3400 world-renowned markets. Our product range includes contracts for difference (CFDs) and unleveraged , direct access to stocks trading.

How did we get started?

Epistocks’s mission is to enable everyone to confidently participate in financial markets through secure, low-friction, innovative platforms that take the complexity out of investing. Underpinning this is a commitment to provide education, robust risk management and transparent pricing to help people trade and invest with confidence. The company aims to empower people to responsibly exercise their value as investors and to positively influence corporate behaviour.

There are lots of fintechs out there - what makes Epistocks so special?

Epistocks is known for its cutting-edge technology and education tools, outstanding user experience and fair pricing.

The platform is enabled with robust risk management controls and transparent pricing while its all-in-one Investmate app delivers extensive financial lessons and educational content to support clients in their investment journey - all designed to make investing simple, secure and intuitive.

How many clients do we have?

We host over 2 million clients on the platform

What is Epistocks’s trading volume?

In Q1 2021, Epistocks reported trading volumes in excess of $82 billion

Are we regulated?

Yes, the Epistocks group has entities that are physically located in both the UK and Cyprus, where they are authorised and regulated by the FCA and CySEC respectively.
In the UK, Capital Com (UK) Limited is authorised and regulated by the Financial Conduct Authority (FCA). While Capital Com SV Investments Limited is authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC), under license number 319/17.
In Australia, we are licenced by the Australian Securities and Investment Commission (ASIC). We are committed to growing our regulatory footprint as we expand into new countries in tandem with regulatory approvals. This is key to our global growth plans.

Our core markets include the UK, Germany, France and the Netherlands. In addition, Epistocks is passported into more than 180 countries.